12 Jan 2022 , 12:16 PM
Bliss GVS Pharma Limited’s credit rating has been revised by Infomerics Valuation and Rating Private Limited with respect to the bank facilities of the company.
The long-term bank facilities Rs84.25cr (increased from Rs70cr) in Exim Bank and Federal Bank have been revised to IVR BBB/ Stable from IVR BBB- / Positive.
The credit rating agency also revised the company’s rating on short-term bank facilities Rs75cr (reduced from Rs90cr) in Federal Bank to IVR A3+ from IVR A3.
At around 12.20 PM, Bliss GVS Pharma Ltd was trading at Rs99.40 per share down by Rs0.05 or 0.05% from its previous closing of Rs99.45 per share on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
